Imagion (ASX:IBX) share price zips 38% higher. Here’s why
Imagion (ASX:IBX) share price zips 38% higher. Here’s why
The Imagion Biosystems Ltd share price is up 38% today following an update on its MagSense HER2 breast cancer study. Here’s what the company announced.
Aaron Teboneras has been a Motley Fool contributor since early August 2020. After graduating from RMIT University with a Business degree, Aaron spent most of his years either travelling or working in various industries. Aaron’s most notable appointments include National Australia Bank, and Computershare where he discovered his passion for the Australian sharemarket. Outside of researching and writing for Motley Fool, Aaron enjoys trekking on adventures across the world and learning new life skills.
Diagnostic imaging: what stock will become the next Pro Medicus?
By Tim Boreham, Editor, The New Criterion
For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries.
Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s because they are cheap and convenient.
The underlying tech hasn’t really moved on since 1895, when German physicist Wilhelm Rongen stumbled on the idea with a heated filament cathode that generates electrons in a vacuum tube.
Computed tomography (CT) scans – which parses X-ray images into ‘slices’ of a body – have been around since the 1970s.
Switzer Daily
13 May 2021
For all the leaps and bounds in medical
science, the know-how behind detecting diseases hasn’t changed much in decades
– or even centuries.
Take X-rays, which are widely used
despite the wee problem of irradiating the patients. And that’s because they
are cheap and convenient.
The underlying tech hasn’t really moved
on since 1895, when Germany physicist Wilhelm Rongen stumbled on the idea with
a heated filament cathode that generates electrons in a vacuum tube.
Computed tomography (CT) scans – which
parses X-ray images into ‘slices’ of a body – have been around since the 1970s.
But now a new breed of ASX players are